Evidence map›Paper›PMID 39739230›Full record

ArticleInflammation2025

LncRNA Tug1 Regulates Post-Stroke Microglial Pyroptosis via PINK1/Parkin-Mediated Mitophagy.

Meiling Yao, Xiaobei Wang, Hao Lin, Hui Shu, Zongtang Xu, Ling Tang, Wenyuan Guo, Pingyi Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. lncRNAInternational journal of molecular medicine · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meiling YaoDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Xiaobei WangDepartment of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830054, China.
Hao LinDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Hui ShuDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Zongtang XuDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Ling TangDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Wenyuan GuoDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Pingyi XuDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China. pingyixu@sina.com.

Funding

Guangdong Basic and Applied Basic Research Foundation 2022B1515230004Guangzhou Municipal Science and Technology Bureau's Basic Research Program for the year 2024 jointly funded by the city and universities 2023A03J01331Key Research and Development Program of Guangzhou (2023B03J0631), Municipal University (Faculty) joint funding project 202102010010the Central government guiding local science and technology development projects ZYYD2022C17the National Natural Science Foundation of China 81870856, 81870992, 82071416Xinjiang Uyghur Autonomous Region Key Research and Development Project 2023B03003Xinjiang Uygur Autonomous Region Natural Science Foundation 2021D01C376
6 · The paper itself

Abstract

Microglia, the central nervous system's primary immune cells, play a key role in the progression of cerebral ischemic stroke, particularly through their involvement in pyroptosis. The long non-coding RNA taurine up-regulated gene 1 (Tug1) is elevated during ischemic stroke and is critical in driving post-stroke neuroinflammation. However, the underlying molecular mechanisms remain unclear. This study explores the biological role of Tug1 and its potential mechanisms in regulating pyroptosis in microglia. We utilized an in vivo photothrombosis (PT) mice model and an in vitro oxygen-glucose deprivation and reperfusion (OGD/R) BV2 cell model to explore the mechanisms underlying ischemic stroke. Initially, we assessed the expression levels of Tug1 in the OGD/R model in vitro and the PT model in vivo. Subsequently, we investigated the impact of Tug1 on microglial pyroptosis by knocking down Tug1, silencing the PTEN-induced putative kinase 1 (Pink1) expression, and employing the mitophagy inhibitor mdivi-1. Tug1 exacerbated microglial pyroptosis by inhibiting mitophagy in both in vivo and in vitro models. The increase in mitophagy observed following Tug1 knockdown was reversed by either silencing Pink1 expression or using the mitophagy inhibitor mdivi-1. This reversal resulted in exacerbated pyroptosis and worsened neurological damage. Further mechanistic studies revealed that Tug1 knockdown significantly reduced microglial pyroptosis and alleviated neuronal damage by enhancing PINK1/Parkin-mediated mitophagy. For the first time, this study reveals that Tug1 promotes hypoxia-induced microglial pyroptosis by inhibiting PINK1/Parkin-mediated mitophagy, potentially providing a promising therapeutic target for ischemic inflammatory injury.

Indexed as

MicrogliaMitophagyProtein KinasesPyroptosisRNA, Long NoncodingStrokeUbiquitin-Protein LigasesAnimalsMiceMice, Inbred C57BLPTEN-Induced Putative Kinaselong non-coding RNA TUG1, mouseparkin proteinProtein KinasesPTEN-Induced Putative KinaseRNA, Long NoncodingUbiquitin-Protein LigasesAutophagyIschemic StrokeLncRNA Tug1Pyroptosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.